Philippines - English - FDA (Food And Drug Administration)

dr. zen's research, inc.; importer: n/a; distributor: n/a - zinc - film coated tablet - 10mg (equivalent to 47.35mg zinc picolinate)

Philippines - English - FDA (Food And Drug Administration)

dr. zen's research, inc. - zinc - film-coated tablet - 10 mg (equivalent to 27.45 mg zinc sulfate monohydrate)

Philippines - English - FDA (Food And Drug Administration)

dr. zen's research, inc.; importer: n/a; distributor: n/a - zinc - film-coated tablet - 40 mg (equivalent to 189.40 mg zinc picolinate)

Philippines - English - FDA (Food And Drug Administration)

dr. zen's research, inc. - ascorbic acid , zinc - capsule - 500 mg (equi to 562.43mg sodium ascorbate)/10mg (equi. to 70mg zinc gluconate)

Philippines - English - FDA (Food And Drug Administration)

dr. zen's research, inc. - zinc - chewable tablet - 10 mg

Philippines - English - FDA (Food And Drug Administration)

dr. zen's research, inc. - ascorbic acid , cholecalciferol , zinc - capsule - 500 mg (equivalent to 562.43 mg sodium ascorbate)/ 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate)

Philippines - English - FDA (Food And Drug Administration)

dr. zen's research, inc. - ascorbic acid , cholecalciferol (vitamin d3) , zinc - capsule - 500 mg (equivalent to 605.20 mg calcium ascorbate)/1,000 iu/10 mg (equivalent to 70 mg zinc gluconate)

Philippines - English - FDA (Food And Drug Administration)

dr. zen's research, inc. - ascorbic acid , zinc - syrup - 100 mg/10 mg (equivalent to 27.45 mg zinc sulfate monohydrate) per 5 ml (orange flavor)

Philippines - English - FDA (Food And Drug Administration)

zen's research, inc. - ascorbic acid , zinc - chewable tablet - 500 mg (equivalent to 562.43 mg sodium ascorbate)/ 10 mg (equivalent to 70 mg zinc gluconate)

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - flumazenil injection, usp is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. flumazenil injection, usp is indicated for the reversal of conscious sedation induced with benzodiazepines (see precautions , pediatric use ). flumazenil injection, usp is contraindicated: • in patients with a known hypersensitivity to flumazenil or benzodiazepines. • in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). • in patients who are showing signs of serious cyclic antidepressant overdose (see warnings ). flumazenil acts as a benzodiazepine antagonist, blocks the effects of benzodiazepines in animals and man, antagonizes benzodiazepine reinforcement in animal models, produces dysphoria in normal subjects, and has had no reported abuse in foreign marketing. although flumazenil has a benzodiazepine-like structure it does not act as a benzodiazepine agonist in man and is not a controlled substance.